Oral sumatriptan in treatment of migraine in 83 patients
Shao Fu, Tan Yong, Yu Hui, Cai Ya
Abstract
Shao Fu, Tan Yong, Yu Hui, Cai Ya
Abstract
Eighty-three patients with migraine(M17, F 66; age 40 ±s 9 a) with 119 migraine attacks were treated with sumatriptan 100 mg,po. Within 4 h, the effective rate was 76.5%, improvement rate 13.4%, with total response rate 89.9%.The remission rates of asociated nausea,vomiting,and photo/phonophobia were 94 %,96%,and 94%,respectively.Therefore,sumatrictan is safe and feasible for the treatment of migraine.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Eighty-three patients with migraine(M17, F 66; age 40 ±s 9 a) with 119 migraine attacks were treated with sumatriptan 100 mg,po. Within 4 h, the effective rate was 76.5%, improvement rate 13.4%, with total response rate 89.9%.The remission rates of asociated nausea,vomiting,and photo/phonophobia were 94 %,96%,and 94%,respectively.Therefore,sumatrictan is safe and feasible for the treatment of migraine.
Key concepts: Phonophobia, Migraine, Sumatriptan, Nausea, Vomiting, Medicine, Anesthesia, Photophobia